Received Sep 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
gastrointestinal side effects; This is a spontaneous report received from a Pharmacist. A female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GASTROINTESTINAL DISORDER (non-serious), outcome "unknown", described as "gastrointestinal side effects". It was unknown if therapeutic measures were taken as a result of gastrointestinal disorder. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received. Additional information: In meeting with pharmacy regional clinical lead, pharmacist stated that a patient told her she knows of more people who are experiencing gastrointestinal side effects from COVID-19 vaccination this year. No additional information was provided on this AE.